Universa Medicina is a distinguished open-access journal published by the Faculty of Medicine, Trisakti University, focusing on a broad spectrum of medical disciplines. It has established itself as a vital resource for researchers, healthcare professionals, and students seeking to advance their knowledge and contribute to medical science since its inception in 2009. With an ISSN of 1907-3062 and an E-ISSN of 2407-2230, the journal emphasizes the dissemination of high-quality research, reviews, and innovative case studies that address critical health issues in both local and global contexts. Although its H-index and Scopus ranking data are not currently available, Universa Medicina's commitment to open access ensures the widest possible reach and impact of its published articles. This journal serves as an essential platform for fostering collaboration and dialogue within the medical community, facilitating the exchange of ideas and advancing the frontiers of health knowledge in Indonesia and beyond.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Nigerian Journal of Basic and Clinical Sciences, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating research in the fields of health policy, medicine, and public health, specifically addressing the unique challenges and advancements within these areas in Nigeria and beyond. With an impressive array of contributions, this journal, recognized under the ISSN 0331-8540 and E-ISSN 2320-477X, aims to foster scholarly communication and offer innovative insights particularly pertinent to developing regions. Despite being positioned in the Q4 category for various medical fields in 2023 and receiving low Scopus ranks, the journal stands out as a valuable resource for aspiring researchers, healthcare professionals, and students aiming to explore basic and clinical sciences. While it follows a traditional publication model, it remains an indispensable source for cutting-edge research and case studies that can significantly impact health outcomes. The journal has been consistently publishing since its inception in 2012 and continues to play an important role in advancing the academic discourse within its scope.

PEDIATRICS IN REVIEW, published by the American Academy of Pediatrics, is a prominent journal dedicated to advancing the understanding of child health and pediatric medicine. With an ISSN of 0191-9601 and E-ISSN 1526-3347, this journal offers a vital resource for pediatricians, researchers, and healthcare professionals seeking to stay informed about the latest trends and findings in the field. Though it operates under a subscription model, it maintains a reputable standing with a category quartile ranking of Q3 in Pediatrics, Perinatology, and Child Health as of 2023, reflecting its impactful contributions to the literature. Spanning over three decades since its inception in 1986, PEDIATRICS IN REVIEW continues to publish insightful reviews and articles that facilitate continuous learning and professional development. Its thoughtful coverage and established reputation make it an essential read for those engaged in pediatric research and clinical practice.

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Khyber Medical University Journal-KMUJ, published by KHYBER MEDICAL UNIVERSITY, serves as a vital platform for the dissemination of research in the fields of Medicine, Dentistry, and Health Professions, among others. Established as an Open Access journal since 2009, KMUJ enables greater accessibility to cutting-edge research, fostering collaboration and knowledge exchange within the medical community. With its headquarters in Kohat, Khyber Pakhtunkhwa, Pakistan, the journal caters to a diverse audience by offering insights into various aspects of healthcare, emphasizing innovation and evidence-based practices. Despite its current Q4 ranking in multiple categories, KMUJ is dedicated to enhancing its impact through rigorous peer-reviewed content, aiming to elevate research standards within the region. As it converges from 2019 to 2024, KMUJ strives to contribute significantly to emerging topics in pharmacology, toxicology, and public health, making it an essential resource for researchers, professionals, and students committed to advancing medical science.

Tropical Medicine and Health is a prestigious open-access journal published by BMC that serves as a vital platform for researchers and health professionals focusing on the fields of tropical medicine, infectious diseases, and public health. With an ISSN of 1348-8945 and an E-ISSN of 1349-4147, the journal has established itself in the academic community since its inception in 2004, bridging the gap between research and real-world applications in managing tropical diseases. Recognized for its quality, it holds a commendable Q2 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories, positioned in the 2023 Scopus rankings within the 85th and 74th percentiles, respectively. Researchers can access high-quality, peer-reviewed articles that contribute significantly to advancing knowledge in the field. With a commitment to fostering open scientific dialogue, Tropical Medicine and Health is not just a journal, but a collaborative space for researchers, students, and practitioners working to improve health outcomes in tropical regions worldwide.

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

Advances in Respiratory Medicine is a distinguished open-access journal published by MDPI, focusing on the latest research and developments in the field of pulmonary and respiratory medicine. Launched in 2015 and operating out of Switzerland, this journal aims to advance scientific discourse and knowledge by providing a platform for researchers, clinicians, and health professionals. With an impressive ISSN of 2451-4934 and an E-ISSN of 2543-6031, it has made its mark in the academic community, reflected by its impact factor and recognition in the Q3 category for Pulmonary and Respiratory Medicine as of 2023. The journal enjoys a ranking of #95 out of 155 in Scopus within its category, providing authors with visibility and the potential for impactful dissemination of their research. Open access since 2022, it ensures that findings are readily available to all, fostering collaboration and innovation across disciplines. With a commitment to quality and rigor, Advances in Respiratory Medicine invites contributions that push the boundaries of existing knowledge, making it an invaluable resource for anyone dedicated to enhancing respiratory health.

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.